JYNARQUE (tolvaptan) Patient Assistance Program
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Jynarque (tolvaptan) is FDA-approved to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD). It is a selective vasopressin V2 receptor antagonist available through a REMS program due to hepatotoxicity risk.
- Without assistance, Jynarque costs commonly run approximately $13,500–$16,000 per 30-day supply.
- Through AffordMyPrescriptions, qualifying patients can access Jynarque for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- There is no generic Jynarque in the U.S. as of 2026. Generic tolvaptan tablets (Samsca generic) are available for hyponatremia indications, but Jynarque is specifically formulated and dosed for ADPKD and is the FDA-approved option for that indication.
What Is Jynarque Prescription Assistance Program?
The Jynarque Prescription Assistance Program is a manufacturer-sponsored initiative that provides Jynarque at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for ADPKD patients at risk of rapid progression who are uninsured or underinsured, as well as Medicare Part D beneficiaries.
Navigating the program on your own means dealing with eligibility verification, nephrology coordination, REMS enrollment, baseline and ongoing liver-function-test documentation, prior-authorization documentation, specialty pharmacy logistics, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and re-certification.
Pharmacy Price Comparison
- Without assistance, Jynarque costs roughly $13,500–$16,000/month. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$15,500 | Save ~$15,430/mo |
| CVS Pharmacy | ~$16,000 | Save ~$15,930/mo |
| Walmart | ~$14,000 | Save ~$13,930/mo |
| Costco | ~$13,700 | Save ~$13,630/mo |
Specialty Pharmacy | ~$14,500 | Save ~$14,430/mo |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Jynarque Prescription Program?
The Patient Assistance Program is free to apply for and provides Jynarque at no medication cost if approved. Our $69.95/month service covers full advocacy.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Jynarque:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $13,500–$16,000 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Jynarque assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Jynarque Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Jynarque:
Jynarque (tolvaptan) is a twice-daily oral selective vasopressin V2 receptor antagonist used to slow kidney function decline in ADPKD. It is the first FDA-approved therapy specifically to slow ADPKD progression — a major therapeutic advance for a disease that previously had only supportive care.
How Jynarque Works:
Autosomal dominant polycystic kidney disease (ADPKD) causes fluid-filled cysts to enlarge and replace normal kidney tissue, leading to progressive loss of kidney function. Vasopressin stimulates the production of cAMP through V2 receptors on kidney collecting ducts, which drives this cyst growth. Tolvaptan selectively blocks these V2 receptors, successfully reducing cAMP production and slowing both cyst growth and kidney function decline. Clinical trials show it slows the decline of estimated glomerular filtration rate (eGFR), though the trade-off includes a risk of hepatotoxicity and significantly increased urine output.
Form and use:
Jynarque is taken orally twice daily, with a larger dose administered in the morning and a smaller dose in the afternoon. Treatment starts at 45 mg in the morning and 15 mg in the afternoon, with a weekly titration up to a target dose of 90 mg and 30 mg. It is taken with food, and patients must drink water freely to manage the resulting aquaresis. Because of safety risks, it is available only through a restricted REMS program, and liver function tests (LFTs) are required at baseline, monthly for the first 18 months, and every 3 months thereafter.
Generic availability:
As of 2026, there is no generic version of Jynarque available in the United States. While generic tolvaptan tablets exist under the name Samsca, they are indicated for hyponatremia and are neither dosed nor FDA-approved for ADPKD. Consequently, Jynarque remains the only FDA-approved disease-modifying therapy specifically available for ADPKD patients. Management also typically relies on important adjunctive measures, such as blood pressure control with ACE inhibitors or ARBs, sodium restriction, and increased water intake.
Warnings:
Jynarque carries a boxed warning for serious and potentially fatal liver injury, necessitating a strict schedule of liver function tests at baseline, every 2 weeks for the first 18 months, monthly to month 30, and every 3 months thereafter. Due to these hepatic risks, the medication is strictly limited to a REMS distribution program. Additional warnings include dehydration, hypernatremia, and significant drug interactions with CYP3A inhibitors and inducers. Furthermore, the resulting aquaresis causes large urine volumes that can interfere with a patient’s sleep and daily activities.
FAQ (Frequently Asked Questions)
How Much Does Jynarque Cost Without Insurance?
Jynarque costs approximately $13,500–$16,000 per 30-day supply. Through AffordMyPrescriptions, qualifying patients receive Jynarque at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
How Will Jynarque Help My ADPKD?
Jynarque slows the rate of kidney function decline (eGFR loss) in ADPKD patients at risk of rapid progression. Clinical trials showed that over 3 years, the rate of eGFR decline was about 1 mL/min/1.73 m² per year slower on tolvaptan than placebo — meaningful over decades of ADPKD progression. Jynarque does not reverse existing cysts or restore lost kidney function; it slows further decline.
Why Do I Need So Many Liver Function Tests?
Tolvaptan can cause serious, potentially fatal liver injury (the boxed warning). Most LFT abnormalities are detected by the rigorous monitoring schedule: baseline, every 2 weeks for the first 18 months, then monthly to month 30, then every 3 months. Significant LFT elevations require Jynarque to be paused or stopped. The Jynarque REMS program ensures monitoring compliance.
What's The Deal With Drinking So Much Water?
Tolvaptan causes ‘aquaresis’ — selective excretion of free water without sodium. You’ll produce large volumes of dilute urine (sometimes 5–10+ liters per day). To prevent dehydration and hypernatremia, drink water freely whenever thirsty. This is a major lifestyle effect — affecting sleep (frequent nighttime urination) and daily life. Plan ahead for water access and bathroom access.
Am I A Candidate For Jynarque?
Jynarque is for ADPKD patients at risk of rapid progression — typically those with confirmed ADPKD diagnosis, eGFR appropriate for the indication, and clinical/imaging evidence of rapid kidney enlargement or eGFR decline. Your nephrologist will determine if you meet criteria. Patients with very advanced kidney disease may not benefit. Patients without rapid progression may not have a favorable risk/benefit balance.
Can I Get Jynarque Through The PAP If I Have Medicare?
Yes. Medicare Part D beneficiaries can typically qualify, especially if you face specialty-tier copays. The manufacturer’s commercial copay savings program is reserved for commercially insured patients only — but the underlying PAP supports Medicare patients who meet income criteria.
What If My Application Is Denied?
If denied, we explore alternatives — optimization of standard ADPKD supportive care (blood pressure control, low-sodium diet, adequate hydration), the manufacturer’s copay program for commercially insured patients, or independent foundations such as the PKD Foundation, National Kidney Foundation, PAN Foundation, or HealthWell Foundation. If we cannot find a path, you won’t be charged our service fee
Take Control of Your Medication Costs
If you are struggling with the high cost of Jynarque, our team may be able to help you access assistance programs designed to make brand specialty ADPKD therapy affordable. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.